Terms: = Sarcomas AND FUBP1, FBP, 8880, ENSG00000162613, FUBP
7 results:
1. Orbital Liposarcoma: A Surveillance, Epidemiology and End Results Database Study.
Chen T; Roelofs KA; Baugh S; Esfandiari M; Rootman DB
Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):93-98. PubMed ID: 37695202
[TBL] [Abstract] [Full Text] [Related]
2. Dosimetric impact of using a commercial metal artifact reduction tool in carbon ion therapy in patients with hip prostheses.
Zhao J; Wang W; Shahnaz K; Wu X; Mao J; Li P; Zhang Q
J Appl Clin Med Phys; 2021 Jul; 22(7):224-234. PubMed ID: 34159721
[TBL] [Abstract] [Full Text] [Related]
3. Irinotecan: 25 years of cancer treatment.
Bailly C
Pharmacol Res; 2019 Oct; 148():104398. PubMed ID: 31415916
[TBL] [Abstract] [Full Text] [Related]
4. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma.
Kim SH; Shin KH; Moon SH; Jang J; Kim HS; Suh JS; Yang WI
Cancer Med; 2017 Jun; 6(6):1311-1322. PubMed ID: 28493412
[TBL] [Abstract] [Full Text] [Related]
5. The proteome profile of the human osteosarcoma U2OS cell line.
Niforou KM; Anagnostopoulos AK; Vougas K; Kittas C; Gorgoulis VG; Tsangaris GT
Cancer Genomics Proteomics; 2008; 5(1):63-78. PubMed ID: 18359981
[TBL] [Abstract] [Full Text] [Related]
6. In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer.
Müller C; Schubiger PA; Schibli R
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1162-70. PubMed ID: 16721570
[TBL] [Abstract] [Full Text] [Related]
7. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
Hwu P; Yang JC; Cowherd R; Treisman J; Shafer GE; Eshhar Z; Rosenberg SA
Cancer Res; 1995 Aug; 55(15):3369-73. PubMed ID: 7614473
[TBL] [Abstract] [Full Text] [Related]
